Polyreactive Salivary Antibodies Linked to Recurrent RTI Severity
By Elana Gotkine HealthDay Reporter
FRIDAY, Aug. 16, 2024 -- For children with recurrent respiratory tract infections (rRTIs), serum antibody levels are not associated with respiratory disease severity, but salivary polyreactive immunoglobulin (Ig)A and Haemophilus influenzae are associated with severity, according to a study published online Aug. 8 in the European Respiratory Journal.
Mischa H. Koenen, from the University Medical Center Utrecht in the Netherlands, and colleagues conducted a prospective cohort study including 100 children aged younger than 10 years with rRTIs, their family members, and healthy health care professionals to examine antibody responses in saliva and their interplay with respiratory microbiota in relation to RTI severity and burden.
The researchers observed no association between serum antibody levels and RTI severity. Overall, 28 and 2 percent of salivary and serum antibodies, respectively, displayed polyreactivity. There was a negative association seen for salivary polyreactive IgA with recurrent lower RTIs (adjusted odds ratio, 0.80) and detection of multiple respiratory viruses (adjusted odds ratio, 0.76). There was a positive association seen for abundance of Haemophilus influenzae with RTI symptom burden (regression coefficient, 0.07).
"Our findings indicate a pivotal role for polyreactive antibodies and the respiratory microbiota in the occurrence and severity of RTI symptoms in children with rRTIs," the authors write. "Understanding local mucosal immunity dynamics is an essential step towards the early identification of children at risk of significant RTI burden."
One author received funding from Seqirus; another author disclosed ties to several pharmaceutical companies.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.